Contact this trialFirst, we need to learn more about you.
Chemotherapy
APG-157 for Head and Neck Cancer
Recruiting1 awardPhase 2
Los Angeles, California
This trial studies APG-157, a dissolvable lozenge taken orally, in patients with advanced Head & Neck Cancer. The goal is to shrink the tumor before main treatments like surgery to improve patient outcomes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service